Advertisement

AIDS and Behavior

, Volume 20, Issue 5, pp 967–972 | Cite as

Late Diagnosis of HIV Infection in Metropolitan Areas of the United States and Puerto Rico

  • H. Irene HallEmail author
  • Tian Tang
  • Lorena Espinoza
Original Paper

Abstract

The majority of persons infected with HIV live in large metropolitan areas and many such areas have implemented intensified HIV testing programs. A national indicator of HIV testing outcomes is late diagnosis of HIV infection (stage 3, AIDS). Based on National HIV Surveillance System data, 23.3 % of persons with HIV diagnosed in 2012 had a late diagnosis in large MSAs, 26.3 % in smaller MSAs, and 29.6 % in non-metropolitan areas. In the 105 large MSAs, the percentage diagnosed late ranged from 13.2 to 47.4 %. During 2003–2012, the percentage diagnosed late decreased in large MSAs (32.2–23.3 %), with significant decreases in 41 of 105 MSAs overall and among men who have sex with men. Sustained testing efforts may help to continue the decreasing trend in late-stage HIV diagnosis and provide opportunities for early care and treatment and potential reduction in HIV transmission.

Keywords

HIV HIV testing Diagnosis Delayed diagnosis Disease stage CD4 count AIDS 

Resumen

La mayoría de las personas infectadas con el VIH viven en grandes áreas metropolitanas y muchas de esas áreas han implementado programas intensivos de pruebas de VIH. Un indicador nacional del resultado de las actividades de pruebas de VIH es el diagnóstico tardío de la infección por VIH (clasificación 3, SIDA). Basado en datos del Sistema Nacional de Vigilancia de VIH, el 23.3 % de las personas con VIH diagnosticadas en 2012 en áreas estadísticas metropolitanas (MSA por sus siglas en inglés) grandes, tuvo un diagnóstico tardío, el 26.3 % en las MSA más pequeñas, y 29.6 % en las áreas no metropolitanas. En las 105 MSA grandes, el porcentaje de diagnósticos tardíos oscilo entre 13.2 % y 47.4 %. Del 2003 al 2012, el porcentaje de diagnósticos tardíos disminuyó en las MSA grandes (del 32.3 % al 23.3 %), con una disminución significativa en 41 de las 105 MSA grandes y entre hombres que tienen sexo con hombres. Los esfuerzos continuos en proveer pruebas de VIH pueden ayudar a continuar la tendencia decreciente de diagnósticos tardíos del VIH, y proporcionar oportunidades para la atención y tratamiento oportuno, y la reducción potencial en la transmisión del VIH.

Notes

Disclaimer

The findings and conclusions in this study are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.

Supplementary material

10461_2015_1241_MOESM1_ESM.docx (40 kb)
Supplementary material 1 (DOCX 40 kb)
10461_2015_1241_MOESM2_ESM.docx (36 kb)
Supplementary material 2 (DOCX 36 kb)
10461_2015_1241_MOESM3_ESM.docx (42 kb)
Supplementary material 3 (DOCX 42 kb)
10461_2015_1241_MOESM4_ESM.docx (34 kb)
Supplementary material 4 (DOCX 34 kb)

References

  1. 1.
    Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR. 2006;55(9):1–17.PubMedGoogle Scholar
  2. 2.
    Moyer VA. U.S. preventive services task force. screening for HIV: U.S. Preventive services task force recommendation statement. Ann Intern Med. 2013;159(1):51–60.PubMedGoogle Scholar
  3. 3.
    Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. May 1, 2014:D1-E47. Available at: http://www.aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf.
  4. 4.
    Centers for Disease Control and Prevention. Expanded testing program—overview. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; August 2011.Google Scholar
  5. 5.
    Centers for Disease Control and Prevention. High-impact HIV prevention: CDC’s approach to reducing HIV infections in the United States. Available at: http://www.cdc.gov/hiv/policies/hip.html. Accessed March 17, 2015.
  6. 6.
    Health Resources and Services Administration. HRSA care action: high-impact prevention. Available at: http://hab.hrsa.gov/deliverhivaidscare/files/high_impact_prevention.pdf. Accessed March 17, 2015.
  7. 7.
    Hutchinson AB, Farnham PG, Duffy N, et al. Return on public health investment: CDC’s expanded HIV testing initiative. J Acquir Immune Defic Syndr. 2012;59(3):281–6.CrossRefPubMedGoogle Scholar
  8. 8.
    Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. NEJM. 2011;365(6):493–505.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Centers for Disease Control and Prevention. HIV testing trends in the United States, 2000–2011. Atlanta, GA: U.S. Department of Health and Human Services, January 2013:1–35. Available at: http://www.cdc.gov/hiv/pdf/testing_trends.pdf. Accessed March 17, 2015.
  10. 10.
    Cooley LA, Oster AM, Rose CE, et al. Increases in HIV testing among men who have sex with men—national HIV behavioral surveillance system, 20 U.S. metropolitan statistical areas, 2008 and 2011. PLoS ONE. 2014;9(9):e104162. doi: 10.1371/journal.pone.0104162.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Centers for Disease Control and Prevention. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United States and 6 dependent areas—2012. HIV Surveillance Supplemental Report 2014;19(3). http://www.cdc.gov/hiv/library/reports/surveillance/. Published November 2014. Accessed February 4, 2015.
  12. 12.
    Centers for Disease Control and Prevention. HIV surveillance report, 2013; 25:76. Available at: http://www.cdc.gov/hiv/library/reports/surveillance/. Published February 2015. Accessed May 17, 2015.
  13. 13.
    Valdiserri RO, Forsyth AD, Yakovchenko V, Koh HK. Measuring what matters: development of standard HIV core indicators across the U.S. Department of Health and Human Services. Public Health Rep. 2013;128(5):354–9.PubMedPubMedCentralGoogle Scholar
  14. 14.
    U.S. Department of Health and Human Services, Office of Disease Prevention and Health Promotion. Healthy People 2020 Objectives. HIV-9 Reduce the proportion of persons with a diagnosis of Stage 3 HIV (AIDS) within 3 months of diagnosis of HIV infection. Available at: https://www.healthypeople.gov/2020/topics-objectives/topic/hiv/objectives. Accessed March 17, 2015.
  15. 15.
    Selik RM, Mokotoff ED, Branson B, Owen SM, Whitmore S, Hall HI. Revised surveillance case definition for HIV infection—United States, 2014. MMWR. 2014;63(RR03):1–10.Google Scholar
  16. 16.
    Office of Management and Budget. Revised definitions of metropolitan statistical areas, new definitions of micropolitan statistical areas and combined statistical areas, and guidance on uses of the delineations of these areas. OMB Bulletin 13-01. http://go.usa.gov/vSyB. Published February 28, 2013. Accessed December 1, 2014.
  17. 17.
    McDavid Harrison K, Kajese T, Hall HI, Song R. Risk factor redistribution of the national HIV/AIDS surveillance data: an alternative approach. Public Health Rep. 2008;123(5):618–27.Google Scholar
  18. 18.
    Hall HI, Song R, Szwarcwald CL, Green T. Time from infection with the human immunodeficiency virus to diagnosis, United States. J Acquir Immune Defic Syndr. 2015;6992:248–51.Google Scholar
  19. 19.
    Lesko CR, Cole SR, Zinski A, Poole C, Mugavero MJ. A Systematic review and meta-regression of temporal trends in adult CD4+ cell count at presentation to HIV care, 1992–2011. Clin Infect Dis. 2013;57(7):1027–37.CrossRefPubMedGoogle Scholar
  20. 20.
    Gray KM, Branson B, Donnell DJ, Beauchamp G, Hu X, Wang Z, El Sadr W, Hall HI. HIV testing in six US cities using behavioral surveillance data for the TLC-Plus (HPTN 065) study. XIX International AIDS Conference. Washington, 2012 [abstract TUPE 293].Google Scholar
  21. 21.
    Centers for Disease Control and Prevention. Results of the expanded HIV testing initiative—25 Jurisdictions, United States, 2007–2010. MMWR. 2011;60(24):805–10.Google Scholar
  22. 22.
    Cooley LA, Wejnert C, Rose CE, Paz-Bailey G, National HIV. Behavioral surveillance study group. Increases in recent HIV testing among men who have sex with men coincide with the centers for disease control and prevention’s expanded testing initiative. Clin Infect Dis. 2015;60(3):483–5.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Burns DN, DeGruttola V, Pilcher CD, et al. Toward an endgame: finding and engaging people unaware of their HIV-1 infection in treatment and prevention. AIDS Res Hum Retrovir. 2014;30(4):217–24.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Xia Q, Kobrak P, Wiewel EW, Torian LV. The high proportion of late HIV diagnoses in the USA is likely to stay: findings from a mathematical model. AIDS Care. 2015;27(2):206–12.CrossRefPubMedGoogle Scholar
  25. 25.
    Xia Q, Torian LV, Shepard CW. Limitations of Indicators of HIV case Finding. Epidemiology. 2015;26(1):e6–8.CrossRefPubMedGoogle Scholar
  26. 26.
    Hayek S; Dietz PM, Van Handel M, et al. Centers for Disease Control and Prevention funding for HIV testing associated with higher state percentage of persons tested. J Public Health Manag Pract. 2015 Feb 12. [Epub ahead of print].Google Scholar

Copyright information

© Springer Science+Business Media New York (outside the USA) 2015

Authors and Affiliations

  1. 1.Division of HIV/AIDS PreventionCenters for Disease Control and PreventionAtlantaUSA
  2. 2.ICF InternationalAtlantaUSA

Personalised recommendations